West Syndrome Market Trends

  • Report ID: 4397
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

West Syndrome Market Trends

Growth Drivers

  • Growing Incidence of Traumatic Brain Injuries to Boost the Market Growth - As of 2019, around 200,000 people were noticed to be hospitalized while nearly 62,000 people died due to traumatic brain injuries in the same year in United States. Traumatic brain injury, shortly known as TBI can affect the functionality of the brain in multiple ways. It is categorized into two categories that are closed and penetrating brain injury. TBI can also cause death and serious disabilities becoming the major cause of death in the United States. Hence, such a higher prevalence is estimated to hike the market growth over the forecast period.

  • Higher Prevalence of Drug Seizure - In 2022-21, about 5500 drug seizures per million inhabitants were observed solely in London.

  • Significant Growth in the Imaging Technology - For instance, the diagnostic imaging devices segment was valued at nearly USD 45 billion in 2022 worldwide.

  • Growing Penetration of Neurological Disorders - Based on the data released by Pan American Health Organization (PAHO), in 2019, about 533,172 people died due to neurological conditions in the United States.

Challenges

  • Shortage of Requisite Equipment and Skilled Medical Professionals - The brain is one of the main organs that helps to regulate movement, coordination, intelligence, and all cognitive functions. So, only a skilled professional can treat the diagnose a disease perfectly. Any errors in the diagnosis will harm the patient. And it is not possible to make skilled doctors available at all times in a hospital which may hinder market growth.
  • Lack of Awareness in the Rural Areas
  • Higher Cost Associated with the Treatment

West Syndrome Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5.2%

Base Year Market Size (2023)

USD 1.05 Billion

Forecast Year Market Size (2036)

USD 2.03 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4397
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of west syndrome is assessed at USD 1.1 Billion.

The west syndrome market size was over USD 1.05 Billion in 2023 and is likely to reach USD 2.03 Billion by the end of 2036, witnessing around 5.2% CAGR during the forecast period i.e., between 2024-2036. Higher prevalence of drug seizures and significant growth in imaging technology are the major factors driving the market growth.

North America is expected to account for largest industry share by 2036, attributed to escalation in the number of people living with traumatic brain injuries.

Marinus Pharmaceuticals, Inc., SK Biopharmaceuticals Co., Ltd., Alkem Laboratories Ltd., Supernus Pharmaceuticals, Inc., Eisai Co., Ltd., Abbott Laboratories, Upsher-Smith Laboratories, LLC., Pfizer Inc., H. Lundbeck A/S, UCB S.A.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample